Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction

NCT03960073 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03960073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2019
Completion date
September 30, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, renal insufficiency, chronic